Top 10 Companies Likely to Transact (September 14 - 18)

Data sourced from Dakota Private Markets, the private fund performance platform powered by Dakota. Learn More | Request Access

Tracking when private companies are nearing a sale, recap, or financing event has always been a guessing game. With thousands of sponsor-backed firms spread across sectors and geographies, most deal teams are forced to react after the market moves.

Investors, bankers, and service providers struggle to know which private companies are gearing up for a transaction or capital raise. Signals are scattered, opaque, and nearly impossible to track across thousands of PE- and VC-backed businesses.

Dakota Private Markets centralizes those signals (holding periods, funding rounds, platform acquisition dates, ownership changes, and exit timing patterns) into one predictive transaction-readiness tool. Instead of waiting for headlines, users can see which companies are showing the strongest likelihood of pursuing a sale, recapitalization, or new financing before the market knows.

Below is our weekly roundup of ten PE- or VC-backed companies that, based on their hold period, financing stage, and last transaction date, appear to be credible candidates for a sale or next-round raise.

Nothing is guaranteed, but these companies fall squarely within the timing windows where sponsors typically look to generate liquidity or secure additional capital.

Top 10 Companies Likely to Transact (September 14 - 18)

1. Space DOTS

Space DOTS is a UK-based space technology company specializing in providing dimensionally optimized technology satellites. Their platform develops novel pico-payloads with proprietary active testing systems and an end-to-end logistics portal, aiming to expedite the on-orbit qualification of advanced materials. This innovation facilitates the transfer of space technology for use in harsh and hard-to-reach environments on Earth.

• Sector: Industrials
• Last known transaction date: Seed Venture, $1.5M, September 2025
• Why timing suggests a near-term transaction: This $1.5M seed round is on the smaller side, likely covering 12-18 months of runway even with typically capital-intensive industrials/hardware burn, suggesting a narrow scope or bridge-style raise. A follow-on raise is plausible in the mid to late 2026 window, sooner than standard industrials norms, tied to early prototype validation.

2. Tipple

Tipple is a Dublin-based e-commerce platform founded in 2022 that enables alcohol brands to sell directly to consumers across Europe. By automating the entire checkout, logistics, and compliance process, Tipple simplifies international alcohol sales, allowing brands to focus on product development and market expansion.

• Sector: Industrials
• Last known transaction date: Seed Venture, $4.7M, September 2025
• Why timing suggests a near-term transaction: The $4.7M seed round should fund roughly 18-24 months of runway consistent with industrials-sector capital intensity. A Series A is probable in the early to mid-2027 window, contingent on early customer or deployment traction.

3. Cascade Bio

Cascade Bio specializes in developing enzyme immobilization kits designed to enhance the sustainability and efficiency of chemical manufacturing processes. Their proprietary technology, Body Armor for Enzymes™, stabilizes enzymes on silica beads, enabling their integration into existing industrial processes with improved performance and longevity.

• Sector: Materials
• Last known funding round: Seed Venture, $2.8M, September 2025
• Why timing suggests a near-term transaction: This $2.8M seed round is modest for a materials-sector venture, likely providing 18-24 months of runway given the capital-intensive nature of the space, though the smaller check size may narrow scope. A Series A raise is plausible in the early to mid-2027 window, tied to early technical validation.

4. Ridge Biotechnologies

Ridge Biotechnologies is a biotechnology company specializing in AI-driven enzyme and targeted drug design to develop precision medicines. Their platform utilizes proprietary machine learning models built on extensive cell-free datasets to design precision enzymes and targeted delivery systems rapidly and at scale. Their product lines include NativeLink, ProTrigger, and Catalytic Medicines, focusing on enhancing therapeutic efficacy and safety.

• Sector: Health Care
• Last known funding round: Seed Venture, $25M, September 2025
• Why timing suggests a near-term transaction: This unusually large $25M seed round should fund 30+ months of runway, well beyond typical seed-stage biotech burn, suggesting an aggressive platform build-out. A Series A is likely to follow in the 2028 window, contingent on R&D milestones.

5. Teton AI

Teton.ai ApS is a Danish healthtech company founded in 2020, specializing in AI-driven solutions for healthcare, particularly in elderly care. Their platform utilizes AI and computer vision to monitor patient activities, providing real-time insights that assist caregivers in delivering proactive and personalized care. The company aims to enhance care quality, reduce staff burnout, and improve operational efficiency in healthcare settings.

• Sector: Health Care
• Last known funding round: Series A Venture, $20M, September 2025
• Why timing suggests a near-term transaction: The $20M Series A likely provides 24-30 months of runway, reflecting biotech/health care R&D and clinical-stage capital intensity. A Series B raise is probable in the mid to late 2027 window, tied to data readouts or regulatory progress.

6. Parento

Parento is a New York-based insurance agency specializing in providing customizable paid parental leave insurance policies for companies. Their services aim to support working parents by offering up to 16 weeks of paid leave, along with comprehensive leave management and personalized coaching programs.

• Sector: Financials
• Last known funding round: Seed Venture, $5.9M, September 2025
• Why timing suggests a near-term transaction: This $5.9M seed round should cover 12-18 months of runway consistent with capital-efficient financials-sector burn. A Series A is likely in the late 2026 to early 2027 window, pending regulatory or early traction milestones.

7. Pathwork

Pathwork is an AI-driven platform established in 2024, headquartered in San Francisco, California, dedicated to revolutionizing the distribution of life and health insurance policies. The company focuses on automating the sales, placement, and retention processes within the insurance sector. Pathwork's suite of products includes the Case Underwriter, Knowledge Assistant, and Pre-App Manager, all designed to streamline underwriting tasks, enhance case management, and improve operational efficiency for brokers and carriers. The leadership team is led by CEO Ian Levinsky, a seasoned insurtech operator committed to leveraging technology to modernize insurance distribution. Pathwork's mission is to empower brokers and carriers to underwrite, place, and retain policies more swiftly and accurately, thereby transforming the insurance distribution landscape.

• Sector: Information Technology
• Last known funding round: Seed Venture, $3.5M, September 2025
• Why timing suggests a near-term transaction: The $3.5M seed round likely funds 12-18 months of runway under typical software-driven IT burn rates. A Series A raise is plausible in the late 2026 to early 2027 window, contingent on product-market fit signals.

8. LightSpun

LightSpun is a healthcare administration technology company specializing in AI-powered automation solutions for payors, providers, and dental service organizations (DSOs). Their platform streamlines processes such as claims administration, credentialing, contact center operations, and more, aiming to enhance patient outcomes, member engagement, and provider experiences.

• Sector: Health Care
• Last known funding round: Series A Venture, $13M, September 2025
• Why timing suggests a near-term transaction: This $13M Series A should provide 24-30 months of runway, reflecting health care/biotech R&D capital intensity. A Series B is probable in the mid to late 2027 window, tied to clinical or technical milestones.

9. Indigrid Technology Pvt Ltd.

Indigrid Technology Pvt Ltd is a forward-thinking company dedicated to revolutionizing electric mobility in India. Founded in 2016 by Rishab Puri and Sameer Narang, the company specializes in manufacturing lithium-ion battery packs and providing electronic system design manufacturing (ESDM) solutions. Their product offerings include advanced battery packs for electric vehicles (EVs), components for EV drivetrains, and hardware for battery swapping stations. Indigrid's mission is to drive the transition towards a greener and more sustainable future by delivering reliable, efficient, and sustainable solutions that cater to the evolving needs of the EV market.

• Sector: Consumer Discretionary
• Last known funding round: Series A Venture, $4M, September 2025
• Why timing suggests a near-term transaction: The $4M Series A is relatively modest for the stage, likely covering 12-18 months of runway under consumer discretionary burn rates, possibly reflecting a leaner or regionally-scoped raise. A Series B raise is plausible in the late 2026 to early 2027 window, contingent on growth traction.

10. Nuclearn

Nuclearn is an AI-driven company specializing in solutions tailored for the nuclear industry. Their platform automates tasks such as condition report coding, CAP screening, trend detection, and safety documentation, aiming to enhance operational efficiency and compliance within nuclear operations.

• Sector: Information Technology
• Last known funding round: Series A Venture, $10.5M, September 2025
• Why timing suggests a near-term transaction: This $10.5M Series A likely funds 18-24 months of runway under software-driven IT burn rates. A Series B is probable in the late 2026 to mid-2027 window, tied to enterprise adoption and revenue growth.

Use Dakota Private Markets' Sponsor Backed Company Intelligence to Spot Likely Exits Before the Market Does

Dakota Private Markets' private company data gives you a real-time view into thousands of sponsor-backed companies, including platform acquisition dates, funding rounds, parent sponsors, add-on activity, and sector categorization.

Instead of guessing where companies are in their lifecycle, you can instantly identify which ones are approaching the typical timing windows for a sale or recap.

This dataset enables deal sourcers, investor relations teams, and allocators to anticipate transactions, build targeted outreach lists, and stay ahead of market announcements, every single day.

Filter by sector, geography, funding stage, last transaction date, or parent sponsor to build the list that matches your mandate.

To explore more companies likely to transact, request access to Dakota Private Markets.